MYST3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.504800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.048000E-01
Normal-vs-Stage2
2.471000E-01
Normal-vs-Stage3
1.144040E-01
Normal-vs-Stage4
9.459800E-01
Stage1-vs-Stage2
2.538600E-01
Stage1-vs-Stage3
4.561900E-02
Stage1-vs-Stage4
8.415800E-01
Stage2-vs-Stage3
1.291370E-01
Stage2-vs-Stage4
2.289200E-01
Stage3-vs-Stage4
6.185700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.262800E-01
Normal-vs-AfricanAmerican
9.099200E-01
Normal-vs-Asian
1.314190E-01
Caucasian-vs-AfricanAmerican
1.547570E-01
Caucasian-vs-Asian
3.915000E-01
AfricanAmerican-vs-Asian
1.034790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.685200E-01
Normal-vs-Female
2.542800E-01
Male-vs-Female
9.451400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.133600E-01
Normal-vs-Age(41-60Yrs)
5.281800E-01
Normal-vs-Age(61-80Yrs)
1.883240E-01
Normal-vs-Age(81-100Yrs)
8.172200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.953400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.906000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.020200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.967960E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.973600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.857400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.261800E-02
Normal-vs-Daily Drinker
7.235700E-02
Normal-vs-Weekly Drinker
1.640350E-01
Normal-vs-Occasional Drinker
3.769000E-01
Normal-vs-Social Drinker
6.078200E-01
Non Drinker-vs-Daily Drinker
6.805000E-01
Non Drinker-vs-Weekly Drinker
9.230200E-01
Non Drinker-vs-Occasional Drinker
1.842640E-01
Non Drinker-vs-Social Drinker
1.919550E-01
Daily Drinker-vs-Weekly Drinker
6.776000E-01
Daily Drinker-vs-Occasional Drinker
1.226560E-01
Daily Drinker-vs-Social Drinker
9.744200E-02
Weekly Drinker-vs-Occasional Drinker
3.360800E-01
Weekly Drinker-vs-Social Drinker
2.674800E-01
Occasional Drinker-vs-Social Drinker
7.160200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.288390E-01
Normal-vs-Grade 2
4.125700E-02
Normal-vs-Grade 3
1.458260E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.976600E-01
Grade 1-vs-Grade 3
3.824400E-01
Grade 1-vs-Grade 4
1.288390E-01
Grade 2-vs-Grade 3
3.142200E-01
Grade 2-vs-Grade 4
4.125700E-02
Grade 3-vs-Grade 4
1.458260E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.884170E-01
Normal-vs-NonDiabetic
1.702030E-01
Diabetic-vs-NonDiabetic
9.637000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.865600E-01
Normal-vs-NoPancreatitis
2.068200E-01
Pancreatitis-vs-NoPancreatitis
5.022800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.786200E-01
Normal-vs-N1
2.649400E-01
N0-vs-N1
5.483600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.409800E-01
Normal-vs-TP53-NonMutant
4.931000E-01
TP53-Mutant-vs-TP53-NonMutant
7.893200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
